{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:23:20Z","timestamp":1775136200901,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Spieren voor Spieren Foundation","award":["SvS15-"],"award-info":[{"award-number":["SvS15-"]}]},{"name":"Duchenne Parent Project Netherlands","award":["2016"],"award-info":[{"award-number":["2016"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ejpn-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejpn.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T06:09:37Z","timestamp":1537510177000},"page":"152-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Methylphenidate use in males with Duchenne muscular dystrophy and a comorbid attention-deficit hyperactivity disorder"],"prefix":"10.1016","volume":"23","author":[{"given":"Judith M.","family":"Lionarons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danique M.J.","family":"Hellebrekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Klinkenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2467-067X","authenticated-orcid":false,"given":"Catharina G.","family":"Faber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan S.H.","family":"Vles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos G.M.","family":"Hendriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2018.09.005_bib1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","article-title":"Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK)","volume":"21","author":"Moat","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ejpn.2018.09.005_bib2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/jpc.12868","article-title":"Duchenne muscular dystrophy","volume":"51","author":"Yiu","year":"2015","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.ejpn.2018.09.005_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0883073807309775","article-title":"Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder","volume":"23","author":"Hendriksen","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2018.09.005_bib4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neubiorev.2013.03.016","article-title":"Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review","volume":"37","author":"Snow","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.ejpn.2018.09.005_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jpeds.2012.03.020","article-title":"Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation","volume":"161","author":"Pane","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.ejpn.2018.09.005_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/brain\/awf012","article-title":"Brain function in Duchenne muscular dystrophy","volume":"125","author":"Anderson","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2018.09.005_bib7","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/ajp.2007.164.6.942","article-title":"The worldwide prevalence of ADHD: a systematic review and metaregression analysis","volume":"164","author":"Polanczyk","year":"2007","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.ejpn.2018.09.005_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0883073807307975","article-title":"Cognitive and psychological profile of males with Becker muscular dystrophy","volume":"23","author":"Young","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2018.09.005_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(18)30026-7","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejpn.2018.09.005_bib10","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/00004583-200111000-00020","article-title":"Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults","volume":"40","author":"Greenhill","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2018.09.005_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ejpn.2017.12.004","article-title":"Brain-related comorbidities in boys and men with Duchenne Muscular Dystrophy: a descriptive study","volume":"22","author":"Hendriksen","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2018.09.005_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/14740338.2017.1301928","article-title":"An update on the safety of psychostimulants for the treatment of attention-deficit\/hyperactivity disorder","volume":"16","author":"Groenman","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ejpn.2018.09.005_bib13","series-title":"Diagnostic and statistical manual of mental disorders: DSM-IV","author":"Frances","year":"1994"},{"key":"10.1016\/j.ejpn.2018.09.005_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejpn.2015.04.004","article-title":"Diagnostic overshadowing in a population of children with neurological disabilities: a cross sectional descriptive study on acquired ADHD","volume":"19","author":"Hendriksen","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2018.09.005_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejpn.2018.09.005_bib16","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2147\/NDT.S130444","article-title":"Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity","volume":"13","author":"Huss","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.ejpn.2018.09.005_bib17","series-title":"Manual for the child behavior checklist and revised child behavior profile","author":"Achenbach","year":"1983"},{"key":"10.1016\/j.ejpn.2018.09.005_bib18","series-title":"Manual for the Wechsler intelligence scale for children-(WISC-III)","author":"Wechsler","year":"1991"},{"key":"10.1016\/j.ejpn.2018.09.005_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00004583-200402000-00015","article-title":"Differential effects of methylphenidate on attentional functions in children with attention-deficit\/hyperactivity disorder","volume":"43","author":"Konrad","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2018.09.005_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-0034-1368117","article-title":"Pharmacotherapy of attention deficit in neurofibromatosis type 1: effects on cognition","volume":"45","author":"Lidzba","year":"2014","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ejpn.2018.09.005_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1017\/S0012162201001876","article-title":"Treatment of ADHD in neurofibromatosis type 1","volume":"44","author":"Mautner","year":"2002","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ejpn.2018.09.005_bib22","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2749","article-title":"Diagnostic accuracy of rating scales for attention-deficit\/hyperactivity disorder: a meta-analysis","volume":"137","author":"Chang","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejpn.2018.09.005_bib23","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1586\/14737175.7.12.1799","article-title":"Sleep problems associated with ADHD: a review of current therapeutic options and recommendations for the future","volume":"7","author":"Lecendreux","year":"2007","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.ejpn.2018.09.005_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s13311-012-0130-0","article-title":"ADHD treatments, sleep, and sleep problems: complex associations","volume":"9","author":"Stein","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejpn.2018.09.005_bib25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00431-003-1207-x","article-title":"Melatonin for treatment of sleeping disorders in children with attention deficit\/hyperactivity disorder: a preliminary open label study","volume":"162","author":"Tjon Pian Gi","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ejpn.2018.09.005_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.chi.0000246055.76167.0d","article-title":"Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia","volume":"46","author":"Van der Heijden","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2018.09.005_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00213-002-1340-7","article-title":"Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma","volume":"166","author":"Volkow","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejpn.2018.09.005_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40263-017-0410-7","article-title":"Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate, amphetamines and atomoxetine","volume":"31","author":"Hennissen","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejpn.2018.09.005_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10862-007-9064-y","article-title":"Parent and teacher ratings on the Iowa Conners rating scale","volume":"30","author":"Waschbusch","year":"2008","journal-title":"J Psychopathol Behav Assess"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379818302344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379818302344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T04:54:48Z","timestamp":1547182488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379818302344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1090379818302344"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2018.09.005","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methylphenidate use in males with Duchenne muscular dystrophy and a comorbid attention-deficit hyperactivity disorder","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}